New Alzheimer’s drug approved by FDA

Updated: Jun. 7, 2021 at 10:05 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

TOLEDO, Ohio (WTVG) - The FDA approved the first new drug to treat Alzheimer’s in 20 years.

The name of the medication is Aduhelm. It’s an infusion every four weeks for a cost of $56,000 a year.

This is not a cure, but rather a treatment for Alzheimer’s diagnosed early in the disease process.

It reduces the build-up of amyloid plaques. This will extend the period of time until the disease robs victims of their memory and ability to communicate.

The FDA is coming under heavy fire from medical experts who claim the drug gained approval without enough evidence that it works. The FDA will require the drug company to perform further drug studies and if evidence doesn’t show it’s working, it will take the rare move of pulling the drug.

Copyright 2021 WTVG. All rights reserved.